Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02765659
Other study ID # 2015-0691
Secondary ID R01NR015409
Status Completed
Phase N/A
First received
Last updated
Start date June 2016
Est. completion date June 30, 2021

Study information

Verified date November 2021
Source University of Illinois at Chicago
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This implementation study is testing whether community members can use a 3-step model (prepare, roll-out and sustain) to implement an efficacious peer group HIV prevention intervention with fidelity and effectiveness in a single district in Southern Malawi. A collaborative partnership including university researchers and district government, health system and traditional leaders will support community volunteers in implementation. Both the implementation process and the effectiveness of the intervention when implemented by communities will be evaluated.


Description:

In response to the National Institutes of Health's call for empirically-supported models to implement research-tested health behavior change interventions, the investigators are testing a 3-step (prepare, roll-out, and sustain) Community Implementation Model (Model) in low-resource African communities. The Model is adapted from a theory-based model that was effective in implementing a hospital-based intervention in South Africa. Its participatory approach, clear steps, observable benchmarks and multimedia Toolkit will facilitate community ownership and build capacity to use the Model with fidelity. The investigators test whether community members can use the Model to effectively implement a peer group HIV prevention intervention called Mzake ndi Mzake (Friend to Friend) with fidelity and effectiveness. Developed and tested among several populations in Malawi (R01-NR08058), This intervention was efficacious in rural, central Malawi. Intervention communities had significantly better outcomes, including higher condom use and HIV testing for both adults and adolescents, than control communities. The investigators evaluate the Model's implementation success in Phalombe District, in southern Malawi, where the HIV prevalence of 14.5% is twice that of other regions. Our implementation partnership builds on the strengths and contributions of four sectors. Traditional community leaders mobilize their communities' assets, including volunteers to implement the peer group intervention. The District health system has formal authority in health organizations, contributes health knowledge, and provides local District health data. The District political administration supports this effort by negotiating donated space for an HIV/AIDS Resource Centre and by pledging funds to sustain and expand implementation of the intervention if communities demonstrate that they can use the Model. Researchers from both US and Malawi universities contribute the Model and the Mzake ndi Mzake peer group intervention, provide supportive technical assistance for program implementation and conduct evaluations. Specific aims and their evaluation are: Aim 1) Prepare and support 3 communities in using the Model to implement Mzake, evaluated with community self-rated benchmarks. Aim 2) Identify implementation patterns across sites and over time, evaluated using mixed-methods to integrate benchmarks with observations, focus groups, and interview. Aim 3) Assess communities' effectiveness in using the Model to implement Mzake, evaluated with a stepped wedge design (N = 864). Analysis uses multi-level hierarchical models to detect improvements over time in HIV-related behavioral outcomes and a symptoms interview with a nurse for sexually transmitted infections (STIs) in participants who have received the intervention compared to the delayed-intervention control group. (Our original plan to use rapid STI tests appropriate for community use had to be modified because of new data indicating unacceptable reliability and withdrawal of one test from the market). Aim 4) Evaluate whether the Model is feasible, acceptable, effective and sustainable when used by communities to implement Mzake, examined by integrating data from Aims 1-3. If successful, this study will advance implementation science by providing a replicable evidence-based model for implementation of HIV prevention interventions and other health interventions by low-resource communities.


Recruitment information / eligibility

Status Completed
Enrollment 1353
Est. completion date June 30, 2021
Est. primary completion date April 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 13 Years and older
Eligibility Inclusion Criteria: - reside in specified community, - parental permission if under age 18 Exclusion Criteria: - not in designated community

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mzake ndi Mzake T1
a 6-session peer group intervention focusing on primary HIV prevention and early testing and entry to treatment for secondary prevention - offered immediately after baseline
Mzake ndi Mzake T2
a 6-session peer group intervention focusing on primary HIV prevention and early testing and entry to treatment for secondary prevention - offered immediately after post-T2 evaluation
Mzake ndi Mzake T3
a 6-session peer group intervention focusing on primary HIV prevention and early testing and entry to treatment for secondary prevention - offered immediately after post-T3 evaluation

Locations

Country Name City State
Malawi Phalombe district communitie Phalombe

Sponsors (3)

Lead Sponsor Collaborator
University of Illinois at Chicago Kamuzu College of Nursing, University of Malawi, National Institute of Nursing Research (NINR)

Country where clinical trial is conducted

Malawi, 

References & Publications (1)

Jere DLN, Banda CK, Kumbani LC, Liu L, McCreary LL, Park CG, Patil CL, Norr KF. A hybrid design testing a 3-step implementation model for community scale-up of an HIV prevention intervention in rural Malawi: study protocol. BMC Public Health. 2018 Aug 2;18(1):950. doi: 10.1186/s12889-018-5800-3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Reported condom use in the last 2 months If used condoms (always, sometimes, never) in last 2 months with all sexual partners Change from baseline up to 33 months to 33 months
Secondary HIV test in last 12 months up to 33 months If reports having an HIV test in the last 12 months Change from baseline up to 33 months
Secondary Reported sexually transmitted infection (STI) symptoms STI symptoms reported during the last week in an interview with a nurse Change from baseline up to 33 months
Secondary Reported high-risk behaviors in the last 2 months Number of risky behaviors: unprotected sex, sex for money, sex while drinking, multiple partners, STI symptoms or positive test Change from baseline up to 33 months
Secondary condom used at last intercourse if reported using a condom the last time had sexual intercourse Change from baseline up to 33 months
See also
  Status Clinical Trial Phase
Completed NCT01722838 - Black Men Evolving Behavioral HIV Prevention Intervention for Black MSM N/A
Withdrawn NCT02206932 - A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C Phase 4